End-of-day quote
Korea S.E.
03:30:00 21/05/2024 am IST
5-day change
1st Jan Change
18,300
KRW
-1.82%
-4.69%
-11.38%
Daewoong Co., Ltd.'s Equity Buyback announced on July 27, 2023, has closed with 690,630 shares, representing 1.66% for KRW 9,997.24 million.
The company closed its plan on January 31, 2024.
Korean Sugar Imports Plunge 14% as Diabetes Cases Surge
24/04
MT
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
08/03
CI
Daewoong Pharmaceutical Secures Approval for Stem Cell Processing Facility in Indonesia
15/02
MT
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.
05/02
CI
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.
31/01
CI
Daewoong Co., Ltd.'s Equity Buyback announced on July 27, 2023, has closed with 690,630 shares, representing 1.66% for KRW 9,997.24 million.
31/01
CI
Zydus Unit, Daewoong Pharma to Co-Develop, Commercialize Leuprolide Acetate in US
11/12
MT
Daewoong Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
14/11
CI
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.
03/11
CI
Hyphens Pharma Unit to Distribute Daewoong Pharmaceutical's Nabota Botox in Malaysia
30/23/30
MT
Daewoong Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
14/23/14
CI
Daewoong Pharmaceutical's Nabota Surpasses 600,000 Customers in the US
02/23/02
MT
Daewoong Co., Ltd. announces an Equity Buyback for KRW 10,000 million worth of its shares.
27/23/27
CI
Daewoong Co., Ltd. authorizes a Buyback Plan.
27/23/27
CI
Avacta sees shares rise on new equity payment for South Korea venture
05/23/05
AN
Daewoong Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
15/23/15
CI
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
08/23/08
CI
An Unknown buyer completed the acquisition of 66.2% stake in Palmpack Co., Ltd. from Daewoong Co., Ltd..
28/23/28
CI
Sonoma Pharmaceuticals Signs Distribution Deal With Daewoong Pharmaceutical to Sell Skin Products in South Korea
31/23/31
MT
Oncorus, Daewoong Pharmaceutical to Develop Lipid Nanoparticle Formulations for mRNA Drug Candidate; Shares Surge
04/23/04
MT
Daewoong Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
14/22/14
CI
Daewoong Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
16/22/16
CI
Daewoong Pharmaceutical Aims to Expand Reach of Nabota Beyond Cosmetic Applications
30/22/30
MT
Avacta JV Extends Drug Manufacturing Agreement With GenScript
16/22/16
MT
Daewoong Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
16/22/16
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Daewoong Co Ltd is a Korea-based holding company engaged in the manufacture and sale of pharmaceuticals. The Company operates its business mainly through subsidiaries including Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd, Daewoong Development Co Ltd, and Hanall Biopharma Co Ltd. Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd and Hanall Biopharma Co Ltd are engaged in the manufacture and sale of pharmaceuticals. Daewoong Development Co Ltd is engaged in real estate rental and supply business. In addition, IDS&Trust Co Ltd manufactures and sells communication-related devices. Daewoong Life Science Co Ltd is engaged in food processing and sales. Pampaeg Co Ltd is engaged in the packaging business of quasi-drugs. Daewoong Management Development Institute Co Ltd is engaged in management and industrial training projects.
More about the company
Last Close Price
18,300
KRW
Average target price
25,000
KRW
Spread / Average Target
+36.61%
Consensus
1st Jan change
Capi.
-11.38% 549M +20.08% 22.46B +18.22% 15.04B +18.94% 13.98B +56.80% 13.15B -10.55% 6.89B -0.05% 6.79B -8.87% 5.73B +14.03% 5.71B +6.11% 4.69B
Generic Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1